Acadia Pharmaceuticals | Revenu Net



Net Income Changement Date
Acadia Pharmaceuticals USD 143.74M 110.98M 2024-12
ALKERMES USD 22.46M 344.61M 2025-03
Alnylam Pharmaceuticals USD -57479000 26.28M 2025-03
Biogen USD 240.5M 26.2M 2025-03
BioMarin Pharmaceutical USD 185.69M 60.74M 2025-03
Bristol-Myers Squibb USD 2.46B 2.38B 2025-03
Corcept Therapeutics USD 30.75M 16.47M 2024-12
Cytokinetics USD -150020000 10.52M 2024-12
Eisai JPY 23.79B 12.68B 2024-12
Eli Lilly USD 2.76B 1.65B 2025-03
Incyte USD 158.2M 43.01M 2025-03
J&J USD 11B 7.57B 2025-03
Moderna USD -971000000 149M 2025-03
Neurocrine Biosciences USD 103.1M 26.7M 2024-12
Pfizer USD 2.97B 2.56B 2025-03
Prothena USD -57956000 1.04M 2024-12
PTC Therapeutics USD -65886000 40.77M 2024-12
Sarepta Therapeutics USD 159.05M 125.44M 2024-12
Ultragenyx Pharmaceutical USD -133385000 131K 2024-12
Vertex Pharmaceuticals USD 913M 132.4M 2024-12



Acadia Pharmaceuticals Revenu Net - Les valeurs actuelles, des données historiques, des prévisions, des statistiques, des tableaux et le calendrier économique - May 2025.